The Drug Development Process
- GlaxoSmithKline, Pfizer Formally Launch Company to Develop New HIV Treatments (November 3, 2009)
Two of the major pharmaceutical companies producing HIV meds have launched a new joint company focused solely on HIV: ViiV Healthcare.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- How HIV Drugs Get Approved (August 9, 2009)
To read PDF, click here
From AIDS InfoNet
- Medical Innovation and Patent Gridlock (June 20, 2005)
[Archived Article]
John James with a different take on why patents tend to stifle innovation in drug development.
In AIDS Treatment News, from AIDS Treatment News
- Truvánadu: Does Gilead's Famed 903 Study Really Show You What They Tell You It Shows? (December 2004)
[Archived Article]
A highly critical examination of the manner in which many clinical trials are designed.
In TAGline, from Treatment Action Group
- Smarter Clinical Trials for Faster Drug Development (August 23, 2004)
[Archived Article]
Experimental drugs are being tested in humans earlier in the development process, which can help speed the drugs' progress -- or their demise.
In AIDS Treatment News, from AIDS Treatment News
- Prominent Medical Group Calls for Full Disclosure on Drug Studies (June 16, 2004)
[Archived Article]
The American Medical Association proposes a national registry to prevent U.S. pharmaceutical companies from hiding negative clinical trial results.
In Boston Globe
- Abbott's Norvir Price Hike Is Bad Medicine (May/June 2004)
[Archived Article]
Bob Huff explains why the December 2003 ritonavir price increase may well doom the development of boosted protease inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Drug Development Process (Winter 2002/2003)
[Archived Article]
In ACRIA Update, from AIDS Community Research Initiative of America
- Monitoring Anti-HIV Medicines: What Is the FDA's Role? (Spring 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Strawberry Pills Forever (March/April 2000)
Jim Pickett provides some tongue-in-cheek advice for the pharmaceutical industry on developing new drugs.
In Positively Aware, from Test Positive Aware Network
- Experimental Treatments: Unapproved but Not Always Unavailable (January/February 2000)
[Archived Article]
In FDA Consumer, from U.S. Food and Drug Administration
- Drug Development: An Overview (Winter 1998/1999)
[Archived Article]
In CRIA Update, from AIDS Community Research Initiative of America
|
|
Advertisement
|
E-Mail
Glossary
Share
